Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Aphelion Managing Partner Ned Scheetz Discusses Medtech Investor’s Unique Approach, Unusual Name

July 30, 2018

Medtech start-ups need more firms like Aphelion Capital, investors willing to wager as little as $200,000 to get a promising idea going. Managing Partner Ned Scheetz discusses the firm’s origins, name, and plans going forward. This is the first of a two-episode package highlighting a unique joint effort between Aphelion and other co-creators of Cardeation Capital.

Ned Scheetz

Managing Partner

Aphelion Capital

Ned has over 20 years of healthcare investing experience. Prior to forming Aphelion, Ned was a partner and managing director with Piper Jaffray Ventures where he focused on investments in emerging medical technology companies. Ned joined Piper from Janus Capital, where he was a senior research analyst covering both healthcare and internet investments. Before beginning his investment career Ned worked in sales and product management for two Fortune 500 firms. Ned is a graduate of Colby College, Duke University's Fuqua School of Business, and was a post-graduate scholar at Oxford University. He has served on numerous private company boards over his career and enjoys working directly with entrepreneurs to help them build their companies in a capital efficient and less dilutive manner.